OXN PR Tablet 20/10 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OXN PR Tablet 20/10 mg, covering 2019-07-17 to 2019-07-17. Get the full timeline:
Most recent: Clinical Trial Update: OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients [Phase 1]